← Feed

DeLuca Richard R.

SEC Form 4 insider
EVP&Pres, Merck Animal Heallth · Merck & Co., Inc. ($MRK)
1 thesis · first seen Aug 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MRKSEC Form 4bearish
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. · 21h agono track record yet
Sold 6,050 @ $130.38 avg · $788,773 · 2026-08-06

Form 4: DeLuca Richard R. sold MRK

DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 6,050 shares of MRK at an average $130.38, roughly $788,773, in a Form 4 filed 2026-08-10.

Now $130.47just now
1d—
3d—
1w—
1m—
3m—
6m—
1y—
View filing on SEC.gov →

End of results.